HOME | Career | Contact us | Safety Reporting
Medical Practitioners > Gastrointestinal disorders > Lafaxid D Tab
Lafaxid D Tab

Composition: Each uncoated Bilayer Extended Release tablet contains: Lafutidine 10 mg (As Immediate Release)Domperidone Maleate IP equivalent to Domperidone  30 mg (As Extended Release)          

Indications: Dyspepsia, GERD, nausea associated with acid peptic disorders, post-operative nausea and vomiting, chronic gastritis.

Adverse events: Constipation, diarrhea, drug rash, nausea or vomiting and dizziness, rarely hypersensitivity reactions, galactorrhoea or gynaecomastia.

Contraindications: Hypersensitivity to any component of this product, in patients with gastro-intestinal hemorrhage, obstruction or perforation, prolactin-releasing pituitary tumor (prolactinoma).

Precautions: Administer with care in patients impaired hepatic function, impaired renal function and patients on dialysis.

Dosage and administration: One tablet once daily. (For detailed information please write to Zuventus Healthcare Limited, 5119, 5th floor, D-Wing, Oberoi Garden Estates, Chandivali, Andheri (E), Mumbai 400 072 or email to medico@zuventus.com).

© 2013. All Rights Reserved. Zuventus HealthCare Ltd.